Home > Result Summaries: Compounds > ondansetron > Result Summary for S3A-155

Result Summary for S3A-155

Result Summary

Protocol ID:	S3A-155
Clinical Study ID:	S3A-155
Official Title:	An evaluation of the effect of chemotherapy on the pharmacokinetics of oral ondansetron (GR38032F).
Phase:	Phase 1
Study Indications or Diseases:	Nausea and Vomiting
Generic Name:	ondansetron
Trade/Product Name:	zofran;zofran
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Oral ondansetron pharmacokinetics: the effect of chemotherapy. Hsyu, P. H., Pritchard, J. F., Bozigian, H. P., Gooding, A. E., Griffin, R. H., Mitchell, R., Bjurstrom, T., Panella, T. L., Huang, A. T., and Hansen, L. A. J Clin Pharmacol 94; 34(7):767-73